
ViewsML
Transforming Precision Medicine and Diagnostics with Virtual Biomarker Staining
Vancouver, United States · $4.9M raised
- Headquarters
- Vancouver
- Employees
- 1–10
- Business Model
- B2B
- Website
- viewsml.com
- Total Funding
- $4.9M
- Last Round
- $4.9M SeedApr 2026
- Rounds
- 1
About
ViewsML uses deep learning to convert routine pathology images into virtual biomarker staining results, eliminating time-consuming and tissue-destructive lab processes. Its platform provides per-cell spatial and quantitative biomarker insights from a single H&E slide, serving pharmaceutical companies, diagnostic labs, and healthcare systems pursuing faster, more scalable precision medicine.
Summary
ViewsML is an Artificial Intelligence company based in Vancouver, United States. It has raised $4.9M in total across 1 round, most recently a $4.9M Seed round in Apr 2026. Investors include Wittington Ventures and Mayo Clinic.
Tech & App Stack
8 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2026
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.

xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
